| This article has been cited by |
| 1 | Taking a look on fungi in cystic fibrosis: More questions than answers | |
| M. Teresa Martín-Gómez |
| Revista Iberoamericana de Micología.2020;37(1)17 |
| [DOI] |
|
| 2 | Spatiotemporal distribution and the passive dispersal of fungal spores through HVAC systems | |
| Wan-Rou Lin,Yung-Hung Ho,Wai Kwan Lee,Hsuan-Min Cheng,Pi-Han Wang |
| Aerobiologia.2022;38(1)13 |
| [DOI] |
|
| 3 | Spatiotemporal distribution and the passive dispersal of fungal spores through HVAC systems | |
| Katie Krone,Alicia Casey |
| Aerobiologia.2020;38(1)349 |
| [DOI] |
|
| 4 | A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus | |
| Laura Peccini,Serena Pennoni,Valeria Mencarini,Marco Saponara,Nicola Palladino,Nicola Principi,Guido Pennoni,Susanna Esposito |
| Pathogens.2019;9(1)15 |
| [DOI] |
|
| 5 | A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus | |
| Salah Abdelbary |
| Pathogens.2020;9(1)15 |
| [DOI] |
|
| 6 | Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis | |
| Claudia Grehn,Patience Eschenhagen,Svenja Temming,Uta Düesberg,Konrad Neumann,Carsten Schwarz |
| Frontiers in Cellular and Infection Microbiology.2021;10(1)15 |
| [DOI] |
|
| 7 | Urban Life as Risk Factor for Aspergillosis | |
| Claudia Grehn,Patience Eschenhagen,Svenja Temming,Uta Düesberg,Konrad Neumann,Carsten Schwarz |
| Frontiers in Cellular and Infection Microbiology.2020;10(1)15 |
| [DOI] |
|
| 8 | Pulmonary Aspergillosis: What the Generalist Needs to Know | |
| Firas El-Baba,Yuqing Gao,Ayman O. Soubani |
| The American Journal of Medicine.2020;133(6)668 |
| [DOI] |
|
| 9 | Mucosal Immunity in Cystic Fibrosis | |
| Christine M. Bojanowski,Shiping Lu,Jay K. Kolls |
| The Journal of Immunology.2021;207(12)2901 |
| [DOI] |
|
| 10 | BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS | |
| Ya. I. Kozlova,E. V. Frolova,A. E. Uchevatkina,L. V. Filippova,O. V. Aak,T. S. Bogomolova,Yu. V. Borzova,V. R. Makhmutova,T. A. Stepanenko,V. D. Kuznetsov,N. V. Vasilyeva,M. V. Shulgina,N. N. Klimko |
| Medical Immunology (Russia).2019;21(5)919 |
| [DOI] |
|
| 11 | Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations | |
| Corinne A. Muirhead,Natalie Lanocha,Sheila Markwardt,Kelvin D. MacDonald |
| Pediatric Pulmonology.2021;56(5)891 |
| [DOI] |
|
| 12 | Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations | |
| Micheál Mac Aogáin,Céline Vidaillac,Sanjay H. Chotirmall |
| Pediatric Pulmonology.2020;56(5)93 |
| [DOI] |
|
| 13 | Light at the End of Tunnel—Managing Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis | |
| Harjinder Singh |
| The Journal of Allergy and Clinical Immunology: In Practice.2020;8(8)2615 |
| [DOI] |
|
| 14 | Pediatric usage of Omalizumab: A promising one | |
| Lin Yu,Huishan Zhang,Jianwei Pan,Leping Ye |
| World Allergy Organization Journal.2021;14(12)100614 |
| [DOI] |
|
| 15 | Pediatric usage of Omalizumab: A promising one | |
| Ibrahim A. Janahi,Abdul Rehman,Noor Ul-Ain Baloch |
| World Allergy Organization Journal.2018;14(12)100614 |
| [DOI] |
|
| 16 | Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions | |
| Samer Hammoudeh,Wessam Gadelhak,Atqah AbdulWahab,Mona Al-Langawi,Ibrahim A. Janahi |
| Multidisciplinary Respiratory Medicine.2019;14(1)100614 |
| [DOI] |
|
| 17 | Pathogenicity and virulence of Aspergillus fumigatus | |
| Kayleigh Earle,Clara Valero,Daniel P. Conn,George Vere,Peter C. Cook,Michael J. Bromley,Paul Bowyer,Sara Gago |
| Virulence.2023;14(1)100614 |
| [DOI] |
|
| 18 | Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis | |
| Meiling Jin,Jo A. Douglass,J. Stuart Elborn,Ritesh Agarwal,William J. Calhoun,Slawomir Lazarewicz,Xavier Jaumont,Meng Yan |
| The Journal of Allergy and Clinical Immunology: In Practice.2023;11(3)896 |
| [DOI] |
|
| 19 | Clinical characteristics of people with cystic fibrosis and frequent fungal infection | |
| T. Spencer Poore,Maxene Meier,Elinor Towler,Stacey L. Martiniano,John T. Brinton,Emily M. DeBoer,Scott D. Sagel,Brandie D. Wagner,Edith T. Zemanick |
| Pediatric Pulmonology.2022;57(1)152 |
| [DOI] |
|
| 20 | Fungal Infection and Inflammation in Cystic Fibrosis | |
| T. Spencer Poore,Gina Hong,Edith T. Zemanick |
| Pathogens.2021;10(5)618 |
| [DOI] |
|
| 21 | Fungal Infection and Inflammation in Cystic Fibrosis | |
| Luciana Pádua Tavares,Izabela Galvão,Maximiliano R Ferrero |
| Pathogens.2022;10(5)554 |
| [DOI] |
|
| 22 | Complications aiguës respiratoires et non respiratoires chez l’adulte mucoviscidosique | |
| H. Lafoeste,L. Regard,C. Martin,G. Chassagnon,P.-R. Burgel |
| Revue de Pneumologie Clinique.2018;74(5)267 |
| [DOI] |
|
| 23 | Complications aiguës respiratoires et non respiratoires chez l’adulte mucoviscidosique | |
| Susanna A. McColley,Kathleen L. Boyne |
| Revue de Pneumologie Clinique.2022;74(5)146 |
| [DOI] |
|
| 24 | Bacterial Interactions with Aspergillus fumigatus in the Immunocompromised Lung | |
| Anatte Margalit,James C. Carolan,Kevin Kavanagh |
| Microorganisms.2021;9(2)435 |
| [DOI] |
|
| 25 | Emerging Fungal Threats in Cystic Fibrosis | |
| C. Schwarz,P. Eschenhagen,J. P. Bouchara |
| Mycopathologia.2021;186(5)639 |
| [DOI] |
|
| 26 | Biology and Function of Exo-Polysaccharides from Human Fungal Pathogens | |
| Krystal Y. Chung,Jessica C. S. Brown |
| Current Clinical Microbiology Reports.2020;7(1)1 |
| [DOI] |
|
| 27 | Laboratory biomarkers in the diagnosis and follow-up of treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis | |
| Sophie Steels,Marijke Proesmans,Xavier Bossuyt,Lieven Dupont,Glynis Frans |
| Critical Reviews in Clinical Laboratory Sciences.2023;60(1)1 |
| [DOI] |
|
| 28 | Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease? | |
| Qianting Lv,Bernadette B.L.J. Elders,Adilia Warris,Daan Caudri,Pierluigi Ciet,Harm A.W.M. Tiddens |
| European Respiratory Review.2021;30(162)210103 |
| [DOI] |
|
| 29 | Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis | |
| Birce Sunman,Dilber Ademhan Tural,Beste Ozsezen,Nagehan Emiralioglu,Ebru Yalcin,Ugur Özçelik |
| Frontiers in Pediatrics.2020;8(162)210103 |
| [DOI] |
|
| 30 | Primary ciliary dyskinesia and fungal infections: Two cases of allergic bronchopulmonary aspergillosis in children | |
| Laura Allaer,Stéphanie Lejeune,Clémence Mordacq,Antoine Deschildre,Caroline Thumerelle |
| Pediatric Pulmonology.2022;57(7)1809 |
| [DOI] |
|
| 31 | How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts | |
| Steven T. Denham,Morgan A. Wambaugh,Jessica C.S. Brown |
| Journal of Molecular Biology.2019;431(16)2982 |
| [DOI] |
|
| 32 | Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse | |
| Amber R. Philp,Texia T. Riquelme,Pamela Millar-Büchner,Rodrigo González,Francisco V. Sepúlveda,L. Pablo Cid,Carlos A. Flores |
| Scientific Reports.2018;8(1)2982 |
| [DOI] |
|
| 33 | The spectrum of pulmonary aspergillosis | |
| Amjad Kanj,Nadine Abdallah,Ayman O. Soubani |
| Respiratory Medicine.2018;141(1)121 |
| [DOI] |
|
| 34 | Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis | |
| Emanuele Delfino,Filippo Del Puente,Federica Briano,Chiara Sepulcri,Daniele Roberto Giacobbe |
| Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine.2019;13(1)117954841984993 |
| [DOI] |
|
| 35 | Prevalence of coccidioidomycosis in cystic fibrosis patients residing in Southern Arizona | |
| Lauren Estrada,Jessica August,Tammy Ojo,Janet Campion |
| Medical Mycology.2021;59(3)309 |
| [DOI] |
|
| 36 | Germination dynamics of allergenic fungal spores in respiratory mucus | |
| Wan-Rou Lin,Szu-Yu Chen,Shih-Ching Hsiao,Pi-Han Wang |
| Aerobiologia.2021;37(2)271 |
| [DOI] |
|
| 37 | Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies | |
| Joshua S. Davis,David Ferreira,Emma Paige,Craig Gedye,Michael Boyle |
| Clinical Microbiology Reviews.2020;33(3)271 |
| [DOI] |
|
| 38 | Prevention of drug-related complications in cystic fibrosis | |
| Renske van der Meer,Daan J. Touw,Harry G.M. Heijerman |
| Current Opinion in Pulmonary Medicine.2019;25(6)666 |
| [DOI] |
|
